Individual and combined effects of vitamin E and lysolecithin supplementation on growth performance, serum biochemistry, antioxidant status, and gene expression in broiler chickens Authors: Abeer A. Kirrella, Karima El-Naggar, Abeer G. Zaki, Safaa E. Abdo, Eman A. Manaa, Asmaa F. Khafaga, Ayham Abdulkader, Mahmoud Alagawany, Yahya Eid, Ibrahim A. Elkhaiat Published: 2026 ABSTRACT To assess their potential benefits in broiler production, the present experiment evaluated the effects of dietary supplementation with vitamin E (Vit E) and lysolecithin (LYSO) on growth performance, blood biochemical changes, intestinal and hepatic morphology, antioxidant status, meat quality, and gene expression. A total of 264 broiler chicks (Avian 48) were randomly assigned to six treatments for 35 days, each treatment containing four replicates of 11 birds. Treatments were arranged as follows: G1): control, G2): vitamin E (200 mg/kg diet), G3) 0.5 g LYSO/kg diet, G4) 1 g LYSO/kg diet, G5) 0.5 g LYSO + Vit E, and G6) 1 g LYSO+ Vit E. Broiler chickens supplemented with 1 g LYSO/kg diet + Vit E demonstrated the highest performance (higher body weight gain and improved feed conversion ratio) among groups (P < 0.05). Carcass and breast muscle weights were significantly increased, whereas abdominal fat was lowered in the supplemented groups (P < 0.05). In addition, dietary supplements improved phagocytic activity, intestinal and hepatic morphology, liver function-related enzymes (lower alanine aminotransferase-ALT, and aspartate aminotransferase-AST), serum lipid profile (lower low-density lipoproteins-LDL and triglycerides, along with higher high-density lipoproteins-HDL levels), and antioxidant enzyme activities (superoxide dismutase-SOD, glutathione peroxidase-GPx, and catalase-CAT), while lowering malondialdehyde (MDA) levels (P < 0.05) in birds fed the combination (1 g LYSO/kg diet + Vit E). The combination also stimulated significant upregulation of growth hormone receptor (GHR) and insulin-like growth factor (IGF-1), and immune response (Interleukins-, IL-10 and IL-1β) related genes (P < 0.05), while the lipogenic gene, ACC, was downregulated (P < 0.05). Dietary supplementation of feed additives increased meat-water holding capacity, tenderness, and color (P < 0.05), with no effect on meat pH. In conclusion, the combined supplementation of LYSO (1 g/kg diet) and vitamin E improved broiler growth, serum lipid profile and liver function, tissue morphology, immune function, antioxidant status, and meat quality, highlighting its potential as an effective nutritional approach in broiler production. Introduction Poultry production has experienced remarkable advancements in recent decades, with increasing demand for high-quality meat and eggs, which contribute significantly to the worldwide food supply (Nassar, 2026). Broiler production faces persistent challenges from rapid growth rates, high metabolic demands, environmental stressors, and the need to optimize feed efficiency while maintaining meat quality and health (Menshawy et al., 2021; Froebel et al., 2026). These challenges and the significant, intensive broiler production often increase their susceptibility to oxidative stress and reduce nutrient utilization efficiency, thereby lowering bird performance (Li et al., 2024). As a major challenge in the commercial poultry production sector, oxidative stress arises when reactive oxygen species (ROS) overwhelm the antioxidant defenses, resulting in damage to vital organic biomolecules such as polyunsaturated fatty acids, proteins, and DNA, and negatively affecting their growth, immunity, and meat quality (Surai et al., 2019). Consequently, dietary strategies that enhance antioxidant defense and improve nutrient digestibility and availability are critical for maintaining health and maximizing productivity (Surai et al., 2019; Hussein et al., 2025). Among these approaches, supplementation with antioxidants such as vitamin E and exogenous emulsifiers like lysolecithin (LYSO) has attracted considerable attention in intensive broiler production. Vitamin E is a well-recognized essential fat-soluble vitamin for poultry, acting as a powerful antioxidant that interrupts the lipid peroxidation chain reaction and protects cellular membranes from oxidative damage, enhances immune function, and improves the bird's ability to cope with environmental and metabolic stressors (Pompeu et al., 2018; Surai et al., 2019). Dietary supplementation with vitamin E has been associated with improved growth performance, antioxidant defense, immune responses, and meat quality in broilers, and enhanced egg production and quality, fertility, and hatchability in laying hens and breeders (Abd El-Ghany, 2022). Poultry diets often incorporate supplemental fat sources to meet birds' energy requirements, but ineffective lipid digestion and absorption, particularly in young birds with immature digestive systems, can lower nutrient utilization and increase oxidative stress, resulting in compromised bird performance (Oketch et al., 2023). Recently, LYSO attracted attention as one of the most powerful emulsifiers. LYSO, a lysophospholipid produced through the enzymatic hydrolysis of lecithin, enhances intestinal micelle formation, thus facilitating lipase activity through an increased surface area, which in turn enhances the digestibility of fats and other nutrients (El‐Katcha et al., 2021; Zhang et al., 2025). Several beneficial effects of LYSO supplementation in broilers have been documented, including improved performance, nutrient digestibility and utilization, intestinal morphological features, antioxidant status, lipid metabolism, and meat quality (Brautigan et al., 2017; Wealleans et al., 2020; Eid et al., 2025). Despite the well-documented individual benefits of lysolecithin in enhancing lipid digestion and absorption and vitamin E as an antioxidant, information on their combined effects in broiler chickens is still limited, and the potential impacts on broiler growth, physiological parameters, and meat quality have not been examined. As a fat-soluble vitamin, vitamin E's bioavailability depends on effective lipid emulsification and micelle formation in the intestine. By enhancing fat digestion and absorption, lysolecithin could improve the uptake and tissue deposition of supplemented vitamin E, augmenting its antioxidant protection, while LYSO itself contributes to better energy utilization (Abdulla et al., 2019; Jaapar et al., 2020). We hypothesized that co-supplementation may provide a potential synergy and result in greater improvements in broiler productive performance and antioxidant defense compared to individual supplementation. Thus, this study was designed to investigate the potential effects of dietary vitamin E and/or LYSO supplementation on broiler growth, relative organ weights, serum biochemical changes, antioxidant status, intestinal and hepatic morphology, meat quality, and physiological functions related to gene expression. Materials and methods Ethical statement The Experimental Animals Care Ethics Committee at Kafrelsheikh University, Kafrelsheikh, Egypt, gave its approval to this work (KFS-IACUC/333/2025), and it was carried out in compliance with the regulations set forth by the Egyptian university. Birds’ management and study design The experiment was conducted using two hundred and sixty-four-one-day-old broiler chicks (Avian 48), which were sourced from a commercial hatchery located in El-Gharbeia governorate, Egypt. Chicks were individually weighed, with 50.43 ± 0.31 g as the average body weight, then divided into six groups, each containing four replicates of 11 birds. Birds were assigned to six treatment groups: G1 received the basal diet (control); G2 received the basal diet supplemented with 200 mg vitamin E/kg diet; G3 and G4 received the basal diet supplemented with 0.5 and 1.0 g LYSO/kg diet, respectively, while G5 and G6 received the corresponding LYSO-supplemented diets combined with 200 mg vitamin E/kg diet. The basal diets (illustrated in Table 1) were formulated according to the nutrient requirements of the Avian 48 catalogue. Birds were fed the starter diet 1-10 days; the grower diet 11-22 days; and the finisher diet 23-35 days. The Lysoforte® lysophospholipid emulsifier (lysolecithin was the main active ingredient) was purchased from Kemin Europa NV in Herentals, Belgium. Vitamin E (α-tocopherol acetate) was purchased from Cairo Pharmaceutical Industries Co., Egypt, with the recommended supplementation level of 200 mg/kg of diet.Table 1Composition and calculated analysis of the basal diets.Ingredients %Starter(1-10 d)Grower(11-22 d)Finisher(23-35 d)Yellow corn56.6561.0063.25Soybean meal (44 %)30.3627.0025.00Corn gluten meal6.505.505.10Soya oil2.002.302.70Dicalcium phosphate11.851.711.50Limestone21.301.201.20Lysine HCL30.250.210.19DL-Methionine 40.130.130.11Choline chloride0.100.100.10Sodium bicarb0.300.300.30Common salt0.200.200.20Threonine0.060.050.05Premix50.300.300.30Calculated analysis (%)*Crude protein21.820.0219.03Calcium0.930.860.81Available Phosphorus0.450.420.38Lysine1.321.191.11Methionine0.530.500.46Threonine0.890.810.79Metabolizable Energy (Kcal/ kg diet)302130833132Calorie/ Protein ratio138.62154.00164.621Dicalcium phosphate (17% Phosphorus and 21% Calcium).2Limestone (contains 34 % calcium).3Lysine = lysine hydrochloride (containing 98% Lysine).4DL-Methionine (Produced by Evonik Co. and containing 99% methionine).5Premix: 3kg of vitamin and mineral mixture contains vitamin A 12,000,000 IU; vitamin D3 2,500,000 IU; vitamin E 10,000 mg; vitamin K3 2000 mg; vitamin B11000 mg; vitamin B2 5000 mg; vitamin B6 1500 mg; vitamin B12 10 mg; niacin 30,000 mg; biotin 50 mg; folic acid 1000 mg; pantothenic acid 10,000 mg; manganese 60,000 mg; zinc 50,000 mg; iron 30,000 mg; copper 4000 mg; iodine 300 mg; selenium 100 mg; and cobalt 100 mg; and calcium carbonate as carrier.⁎Calculated according to (NRC, 1994). Table 1Composition and calculated analysis of the basal diets.Ingredients %Starter(1-10 d)Grower(11-22 d)Finisher(23-35 d)Yellow corn56.6561.0063.25Soybean meal (44 %)30.3627.0025.00Corn gluten meal6.505.505.10Soya oil2.002.302.70Dicalcium phosphate11.851.711.50Limestone21.301.201.20Lysine HCL30.250.210.19DL-Methionine 40.130.130.11Choline chloride0.100.100.10Sodium bicarb0.300.300.30Common salt0.200.200.20Threonine0.060.050.05Premix50.300.300.30Calculated analysis (%)*Crude protein21.820.0219.03Calcium0.930.860.81Available Phosphorus0.450.420.38Lysine1.321.191.11Methionine0.530.500.46Threonine0.890.810.79Metabolizable Energy (Kcal/ kg diet)302130833132Calorie/ Protein ratio138.62154.00164.621Dicalcium phosphate (17% Phosphorus and 21% Calcium).2Limestone (contains 34 % calcium).3Lysine = lysine hydrochloride (containing 98% Lysine).4DL-Methionine (Produced by Evonik Co. and containing 99% methionine).5Premix: 3kg of vitamin and mineral mixture contains vitamin A 12,000,000 IU; vitamin D3 2,500,000 IU; vitamin E 10,000 mg; vitamin K3 2000 mg; vitamin B11000 mg; vitamin B2 5000 mg; vitamin B6 1500 mg; vitamin B12 10 mg; niacin 30,000 mg; biotin 50 mg; folic acid 1000 mg; pantothenic acid 10,000 mg; manganese 60,000 mg; zinc 50,000 mg; iron 30,000 mg; copper 4000 mg; iodine 300 mg; selenium 100 mg; and cobalt 100 mg; and calcium carbonate as carrier.⁎Calculated according to (NRC, 1994). Composition and calculated analysis of the basal diets. Dicalcium phosphate (17% Phosphorus and 21% Calcium). Limestone (contains 34 % calcium). Lysine = lysine hydrochloride (containing 98% Lysine). DL-Methionine (Produced by Evonik Co. and containing 99% methionine). Premix: 3kg of vitamin and mineral mixture contains vitamin A 12,000,000 IU; vitamin D3 2,500,000 IU; vitamin E 10,000 mg; vitamin K3 2000 mg; vitamin B11000 mg; vitamin B2 5000 mg; vitamin B6 1500 mg; vitamin B12 10 mg; niacin 30,000 mg; biotin 50 mg; folic acid 1000 mg; pantothenic acid 10,000 mg; manganese 60,000 mg; zinc 50,000 mg; iron 30,000 mg; copper 4000 mg; iodine 300 mg; selenium 100 mg; and cobalt 100 mg; and calcium carbonate as carrier. Calculated according to (NRC, 1994). The experiment was conducted over 35 days in an environmentally controlled house. Birds were housed in floor pens measuring 1 m × 1.5 m (1.5 m² per pen), with an experimental stocking density of 0.136 m2 per bird of floor space. All birds had ad libitum access to feed and water supply, as each pen was equipped with a manual feeder and drinker. The heights of feeders and drinkers were adjusted with the birds' age to ensure adequate access. Chicks were brooded at 33°C at the start of the experiment, then the temperature was lowered by 3°C each week until it reached 23°C, which was maintained throughout the rest of the experimental period. The relative humidity was kept within a range of 50–70% during the experiment. The lighting program was set at 23 h light: 1 h dark during the first week, followed by 18 h light: 6 h dark for the remainder of the experiment. Throughout the rearing period, birds were subjected to veterinary-supervised health management procedures, including a vaccination program to protect birds against Newcastle disease, Gumboro disease, infectious bronchitis, and avian influenza. Birds were also monitored daily for clinical signs of illness. The mortality rate was within the normal physiological range (3-5%). Growth performance evaluation Average body weight gain (BWG) and feed conversion ratio (FCR) were calculated using weekly records of birds’ body weight (BW) and feed consumption. FCR was computed using the formula FCR = feed consumed (g)/weight gain (g). Sample collection At the end of the experiment, 4 birds from each treatment (1 per replication) were randomly chosen, weighed, and used for carcass, blood, and tissue sampling. Whole blood samples (n=4 birds/group) were collected from the wing vein of each bird using heparinized syringes to evaluate phagocytic activity. For serum separation, sterile non-heparinized syringes were used to collect blood samples, which were then centrifuged at 2,500 xg and 4°C for 15 minutes. Serum samples were kept at -20°C for biochemical analysis. After blood sampling, birds were slaughtered, left to bleed completely, and eviscerated. The weight of the carcass, breast, thigh muscle, liver, spleen, abdominal fat, and heart was recorded and calculated relative to the live bird weight. After that, liver and jejunum specimens were taken from each bird, preserved in 10% formalin, and used for histological analysis. Another two liver samples were collected; one was kept in liquid nitrogen, then transferred to -80°C for gene expression, and the other was used for the assessment of the hepatic antioxidants. Also, breast muscle samples were collected and stored at 4°C before analysis of meat quality parameters. Histomorphometry parameters of the intestine and liver The jejunum and liver specimens (n=4 birds/group) were collected and preserved in 10% neutral buffered formalin for 24 h. Then, samples were prepared and stained with hematoxylin and eosin stain according to Bancroft et al. (2013). The prepared tissue sections were examined microscopically for histopathological alterations using a light microscope (Leica DM500; Leica Microsystems, Japan). The morphometric parameters were measured in three villi per bird, and the number of microscopic fields was five. The intestinal morphometry measures, including villus height, villus width, crypt depth, and muscularis thickness, were determined using an automated image analysis system (ImageJ; Bethesda, MD, USA) (Schneider et al., 2012). Serum biochemical parameters Colorimetric assays (n=4 birds/group) were employed to determine serum total protein, albumin, globulin, total cholesterol, triglycerides, high- and low-density lipoproteins (HDL and LDL), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and creatinine using commercial kits supplied by Diamond Diagnostics, Cairo, Egypt, following the manufacturer’s instructions. Phagocytosis assay The leukocyte phagocytic activity (PA) against Candida albicans was evaluated according to Kawahara et al. (1991).PA=No.ofmacrophagecontainingyeastNo.ofmacrophages×100PI=No.ofphaocytizedyeastcellsNo.ofphagocyticcells Hepatic antioxidants Liver tissues (n=4 birds/group) were homogenized in a sterile cold potassium phosphate buffer (pH 7). The prepared homogenates were then utilized for the assessment of total antioxidant capacity (TAC), superoxide dismutase (SOD), glutathione peroxidase (GPx), catalase (CAT), and malondialdehyde (MDA) concentrations according to El-Kassas et al. (2019). Total RNA extraction and real-time qPCR The hepatic RNA (n=4 birds/group) was extracted using Trizol (iNtRON Biotechnology). RNA quality was examined using 2% ethidium bromide-stained agarose gel. The mRNA complementary DNA (cDNA) was synthesized using a commercial cDNA synthesis kit (Applied Biotech, Egypt) following the manufacturer's instructions. Real-time PCR system (Strat a gene MX300P Real-time PCR machine (Agilent Technologies, USA) was used for the assessment of the transcriptomic level of some growth, immune response, antioxidants, and fat metabolism-related genes using specific primer pairs listed in Table 2. A total reaction mixture of 20 μL was used, containing 10 μL of 2X SYBR Green Lo-Rox kit (Applied Biotech, Egypt), 2 μL of cDNA, and 0.5 μM of each primer. The thermocycler protocol was done according to El-Kassas et al. (2019) and a specific primer annealing temperature (Table 2) for 30 s. All real-time PCRs were tested in duplicate. The relative gene expression levels (fold change) were calculated using the method outlined by Livak and Schmittgen (2001). The average of two housekeeping genes (B-actin and GAPDH) was used to normalize the data.Table 2Primers of candidate genes for mRNA expression analysis.GenePrimerAnnealingslopeEfficiency %Amplicon (bp)AccessionReferenceB- actinF: ACCTGAGCGCAAGTACTCTGTCTR: CATCGTACTCCTGCTTGCTGAT60-3.3599.2595NM_205518.1(El-Kassas et al., 2018)GAPDHF: TGCCATCACAGCCACACAGAAGR: ACTTTCCCCACAGCCTTAGCAG60-3.4096.72123AF047874.1(Gewaily et al., 2025)Il-10F: CAGACCAGCACCAGTCATCAR: TCCCGTTCTCATCCATCTTCTC61-3.3798.07163NM_001004414.2IL-1BF: TGCCTGCAGAAGAAGCCTCGR: GACGGGCTCAAAAACCTCCT61-3.3997.24204NM_204524.1GPXF: GCGACTTCCTGCAGCTCAACGAR: CGTTCTCCTGGTGCCCGAAT60-3.3798.0399NM_001277853(El-Kassas et al., 2018)SODF: CGGGCCAGTAAAGGTTACTGGAAR:TGTTGTCTCCAAATTCATGCACATG60-3.4196.4583NM_205064.1(Abdo et al., 2017)CATF: ACTGGTGCTGGCAACCCR: ACGTGGCCCAACTGTCAT60-3.31100.5057NM_001031215GHRF: AACACAGATACCCAACAGCCR: AGAAGTCAGTGTTTGTCAGGG60-3.3399.66145XM_046934917.1(El-Naggar et al., 2019)IGF1F: CACCTAAATCTGCACGCTR: CTTGTGGATGGCATGATCT60-3.4096.80140NM_001004384.3FASF: GGAAGATCTGGAGGCTCGTGR: AAAGGAAGCAGCAGCAAAGC63-3.3698.44100NM_205155.2ACCF: AATGGCAGCTTTGGAGGTGTR: TCTGTTTGGGTGGGAGGTG63-3.3097.23136NM_205505GAPDH: glyceraldehyde 3-phosphate dehydrogenase, IL-10: interleukin 10, IL-1B: interleukin 1B, GPx: glutathione peroxidase, SOD: superoxide dismutase, CAT: catalase, GHR: growth hormone receptor, IGF: insulin-like growth factor, FAS: fatty acid synthetase, ACC: acetyl-CoA carboxylase. Table 2Primers of candidate genes for mRNA expression analysis.GenePrimerAnnealingslopeEfficiency %Amplicon (bp)AccessionReferenceB- actinF: ACCTGAGCGCAAGTACTCTGTCTR: CATCGTACTCCTGCTTGCTGAT60-3.3599.2595NM_205518.1(El-Kassas et al., 2018)GAPDHF: TGCCATCACAGCCACACAGAAGR: ACTTTCCCCACAGCCTTAGCAG60-3.4096.72123AF047874.1(Gewaily et al., 2025)Il-10F: CAGACCAGCACCAGTCATCAR: TCCCGTTCTCATCCATCTTCTC61-3.3798.07163NM_001004414.2IL-1BF: TGCCTGCAGAAGAAGCCTCGR: GACGGGCTCAAAAACCTCCT61-3.3997.24204NM_204524.1GPXF: GCGACTTCCTGCAGCTCAACGAR: CGTTCTCCTGGTGCCCGAAT60-3.3798.0399NM_001277853(El-Kassas et al., 2018)SODF: CGGGCCAGTAAAGGTTACTGGAAR:TGTTGTCTCCAAATTCATGCACATG60-3.4196.4583NM_205064.1(Abdo et al., 2017)CATF: ACTGGTGCTGGCAACCCR: ACGTGGCCCAACTGTCAT60-3.31100.5057NM_001031215GHRF: AACACAGATACCCAACAGCCR: AGAAGTCAGTGTTTGTCAGGG60-3.3399.66145XM_046934917.1(El-Naggar et al., 2019)IGF1F: CACCTAAATCTGCACGCTR: CTTGTGGATGGCATGATCT60-3.4096.80140NM_001004384.3FASF: GGAAGATCTGGAGGCTCGTGR: AAAGGAAGCAGCAGCAAAGC63-3.3698.44100NM_205155.2ACCF: AATGGCAGCTTTGGAGGTGTR: TCTGTTTGGGTGGGAGGTG63-3.3097.23136NM_205505GAPDH: glyceraldehyde 3-phosphate dehydrogenase, IL-10: interleukin 10, IL-1B: interleukin 1B, GPx: glutathione peroxidase, SOD: superoxide dismutase, CAT: catalase, GHR: growth hormone receptor, IGF: insulin-like growth factor, FAS: fatty acid synthetase, ACC: acetyl-CoA carboxylase. Primers of candidate genes for mRNA expression analysis. GAPDH: glyceraldehyde 3-phosphate dehydrogenase, IL-10: interleukin 10, IL-1B: interleukin 1B, GPx: glutathione peroxidase, SOD: superoxide dismutase, CAT: catalase, GHR: growth hormone receptor, IGF: insulin-like growth factor, FAS: fatty acid synthetase, ACC: acetyl-CoA carboxylase. Determination of meat pH, color, tenderness, and water-holding capacity The meat quality parameters were assessed 24 h post-mortem using an internal section of the left pectoral major muscle (n=4 birds/group). The pH of meat was measured using a pH meter (Bye model 6020, USA) (Park et al., 2021). The apparatus was calibrated using certified buffer solutions at pH 4.01 and 7.0. Meat extract color intensity was assessed according to Hunt (1991) and Mohamed et al. (2024). As summarized, 10 g of meat was mixed with 22.5 ml distilled water and shaken for 10 min under dark conditions. The absorbance of the resulting filtrate was then measured at 542 nm using a spectrophotometer. Meat tenderness and water-holding capacity (WHC) were assessed (El-Seesy, 2000; Mohamed et al., 2024). Approximately 0.3 g of minced meat was placed under Whatman No. 41 ashless filter paper and subjected to a 1-kg load for 10 min. Following compression, two clearly distinguishable zones appeared on the filter paper. Subsequently, the surface areas of these zones were measured using a planimeter. Tenderness was estimated by the surface area of the internal zone produced by the meat compression. The water-holding capacity was represented by the difference between the area of the inner and outer zones. Statistical analysis Data were analyzed using one-way ANOVA followed by Tukey’s post hoc test using IBM SPSS Statistics (version 22, SPSS Inc., IL, USA). The cage served as the experimental unit for all statistical analyses. Differences were considered statistically significant at P < 0.05. Data normality and variance homogeneity were confirmed via the Shapiro–Wilk and Levene’s tests. Graphical representations were prepared using GraphPad Prism 9 (©Graph Prism Software, La Jolla, CA, USA). Results were presented as mean ± SE. Results Broiler performance and organs' relative weights As illustrated in Table 3, dietary LYSO and vitamin E supplementation significantly affected final BW, WG, and FCR. Birds raised on the combined mixture of 1 g LYSO/kg diet + Vit. E (G6) achieved the highest final BW and WG and improved FCR compared to other groups (P < 0.05). Feed consumption was not significantly affected by dietary treatments (P > 0.05). The carcass characteristics, including the carcass, breast muscle, and abdominal fat relative weights, were significantly influenced by the dietary treatments (P < 0.05) (Table 4). Birds fed a 1 g LYSO/kg supplemented diet (G4) showed the highest carcass percentage compared to the control birds (G1), which recorded the lowest carcass yield. The highest breast muscle yield was observed in birds fed 0.5 g LYSO, 0.5 g LYSO + vitamin E, and 1 g LYSO + vitamin E (G3, G5, and G6), relative to the control birds (P < 0.05). Birds that received the supplemented diets exhibited a significantly lower abdominal fat percentage compared with the control, with the lowest fat % observed in those fed the combined mixture of 1 g LYSO + vitamin E (G6) (P < 0.05). Thigh, liver, spleen, and heart relative weights remained unaffected among groups (P > 0.05).Table 3Growth performance of broiler chickens in response to dietary supplementation with vitamin E and lysolecithin (LYSO).ControlVit E0.5 g LYSO1 g LYSO0.5 g LYSO+ Vit E1 g LYSO+ Vit EP-valueInitial body weight (g)50.80±0.1750.27±0.1950.33±0.4250.53±0.4750.40±0.1550.27±0.450.860Final body weight (g)2225.1±14.30c2347.3±24.07b2316.2±11.26 b2332.0±10.36 b2341.2±18.31 b2498.4±14.08a0.0001Body weight gain (g)2174.3±14.38 c2297.0±24.24 b2265.8±11.65 b2281.5±10.80 b2290.8±18.33 b2448.8±13.67 a0.0001Feed intake (g)3429.1±14.343419.0±10.53417.1±17.663413.1±23.243379.7±14.983416.7±31.160.617FCR1, g/g1.60±0.00a1.47±0.03 ab1.50±0.00 b1.50±0.00b1.46±0.03ab1.40±0.00 c0.0001Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05.1Feed conversion ratioTable 4Organ relative weights of broiler chickens supplemented with vitamin E and lysolecithin (LYSO).Parameterg/100 g body weightControlVit E0.5 g LYSO1 g LYSO0.5 g LYSO+ Vit E1 g LYSO+ Vit EP-valueCarcass68.53±1.20b75.78±0.95ab75.63±1.21ab79.67±4.67a74.05±0.64ab74.23±0.34ab0.039Breast muscle19.20±2.11b24.60±0.54 ab25.48±0.77 a24.95±1.80 ab25.62±0.51 a25.42±1.33 a0.022Thigh muscle15.82±0.2813.70±2.7415.37±0.3815.63±0.4216.05±0.3916.30±0.230.673Liver1.72±0.0231.80±0.0771.70±0.0731.76±0.0741.82±0.0721.60±0.0540.214Spleen0.09±0.0200.07±0.0110.88±0.0180.08±0.0230.09±0.0330.07±0.0220.984Abdominal fat1.05±0.051a0.680±0.084b0.672±0.047b0.705±0.063b0.645±0.059b0.588±0.042b0.0001Heart0.51±0.0120.57±0.0510.49±0.0180.47±0.0430.49±0.0160.45±0.0.260.142Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05. Table 3Growth performance of broiler chickens in response to dietary supplementation with vitamin E and lysolecithin (LYSO).ControlVit E0.5 g LYSO1 g LYSO0.5 g LYSO+ Vit E1 g LYSO+ Vit EP-valueInitial body weight (g)50.80±0.1750.27±0.1950.33±0.4250.53±0.4750.40±0.1550.27±0.450.860Final body weight (g)2225.1±14.30c2347.3±24.07b2316.2±11.26 b2332.0±10.36 b2341.2±18.31 b2498.4±14.08a0.0001Body weight gain (g)2174.3±14.38 c2297.0±24.24 b2265.8±11.65 b2281.5±10.80 b2290.8±18.33 b2448.8±13.67 a0.0001Feed intake (g)3429.1±14.343419.0±10.53417.1±17.663413.1±23.243379.7±14.983416.7±31.160.617FCR1, g/g1.60±0.00a1.47±0.03 ab1.50±0.00 b1.50±0.00b1.46±0.03ab1.40±0.00 c0.0001Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05.1Feed conversion ratio Growth performance of broiler chickens in response to dietary supplementation with vitamin E and lysolecithin (LYSO). Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05. Feed conversion ratio Table 4Organ relative weights of broiler chickens supplemented with vitamin E and lysolecithin (LYSO).Parameterg/100 g body weightControlVit E0.5 g LYSO1 g LYSO0.5 g LYSO+ Vit E1 g LYSO+ Vit EP-valueCarcass68.53±1.20b75.78±0.95ab75.63±1.21ab79.67±4.67a74.05±0.64ab74.23±0.34ab0.039Breast muscle19.20±2.11b24.60±0.54 ab25.48±0.77 a24.95±1.80 ab25.62±0.51 a25.42±1.33 a0.022Thigh muscle15.82±0.2813.70±2.7415.37±0.3815.63±0.4216.05±0.3916.30±0.230.673Liver1.72±0.0231.80±0.0771.70±0.0731.76±0.0741.82±0.0721.60±0.0540.214Spleen0.09±0.0200.07±0.0110.88±0.0180.08±0.0230.09±0.0330.07±0.0220.984Abdominal fat1.05±0.051a0.680±0.084b0.672±0.047b0.705±0.063b0.645±0.059b0.588±0.042b0.0001Heart0.51±0.0120.57±0.0510.49±0.0180.47±0.0430.49±0.0160.45±0.0.260.142Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05. Organ relative weights of broiler chickens supplemented with vitamin E and lysolecithin (LYSO). Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05. Intestinal and liver morphology Intestinal morphometry presented in Table 5 was significantly improved by dietary supplementation of Vit E and/or LYSO (P < 0.05) compared to the control group. Birds fed 1 g LYSO + Vit. E (G6) showed the highest villus height, villus width, crypt depth, and muscularis thickness, followed by 0.5 g LYSO + Vit. E (G5) compared to the control birds, with intermediate values of these parameters when each supplement was given alone. As presented in Figure 1, the control birds (Fig. 1-A) revealed normal intestinal villi lined with simple columnar epithelium with numerous goblet cells. The lamina propria submucosa contained simple tubular intestinal glands, along with the lamina muscularis mucosae and the tunica muscularis (muscularis externa), which was surrounded externally by serosa covering. Supplementation with Vit. E alone (Fig. 1-B) significantly improved the histological structure, including increased villous thickness, villous branching, and a larger area of simple tubular glands within the lamina propria. Birds supplemented with LYSO (Fig. 1-C, D) showed enhanced villus morphology, with well-organized enterocytes that increased the absorptive surface and more extensive intestinal glands, especially at 1 g LYSO/kg of diet (Fig. 1-D). Co-supplementation of Vit E and LYSO led to further improvements in the intestinal mucosa, characterized by branched villi and an expanded area of intestinal glands (Fig. 1-E-F).Table 5Intestinal morphology of broiler chickens supplemented with vitamin E and lysolecithin (LYSO).ParameterControlVit E0.5 g LYSO1 g LYSO0.5 g LYSO+ Vit E1 g LYSO+ Vit EP-ValueVilli height (μm)321.6± 10.42c427±5.96ab345.5±13.68c420.6±15.38b457.9±15.75ab482.6±10.84a0.0001Base width of villi (μm)93.77±1.88e117.57±3.46cd104.23±1.08de122.60±2.88bc134.73±1.87ab145.37±6.85a0.0001Villi crypt (μm)125.87±1.92c161.87±3.78b127.87±3.00c151.53±4.14b149.17±3.21b188.60±1.95a0.0001Muscularis thickness(μm)93.8±2.05d160.67±3.31b111.27±2.25c153.77±1.40b103.8±1.03c180.6±0.46a0.0001Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05.Figure 1Photomicrograph of the intestine in broiler chickens supplemented with vitamin E and lysolecithin (LYSO). A): control, B) vitamin E, C) 0.5 g LYSO/kg diet, D) 1 g LYSO/kg diet, E) 0.5 g LYSO + Vit. E, F) 1 g LYSO + Vit. E. The histological structure of the intestine presented the appearance of intestinal villi (red arrowhead), intestinal glands (IG), lamina muscularis mucosae (m), and muscularis externa (M), which was covered by serosa (blue arrowhead) outwardly. Stain, H&E. Bar, 100 μm. Table 5Intestinal morphology of broiler chickens supplemented with vitamin E and lysolecithin (LYSO).ParameterControlVit E0.5 g LYSO1 g LYSO0.5 g LYSO+ Vit E1 g LYSO+ Vit EP-ValueVilli height (μm)321.6± 10.42c427±5.96ab345.5±13.68c420.6±15.38b457.9±15.75ab482.6±10.84a0.0001Base width of villi (μm)93.77±1.88e117.57±3.46cd104.23±1.08de122.60±2.88bc134.73±1.87ab145.37±6.85a0.0001Villi crypt (μm)125.87±1.92c161.87±3.78b127.87±3.00c151.53±4.14b149.17±3.21b188.60±1.95a0.0001Muscularis thickness(μm)93.8±2.05d160.67±3.31b111.27±2.25c153.77±1.40b103.8±1.03c180.6±0.46a0.0001Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05. Intestinal morphology of broiler chickens supplemented with vitamin E and lysolecithin (LYSO). Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05. Photomicrograph of the intestine in broiler chickens supplemented with vitamin E and lysolecithin (LYSO). A): control, B) vitamin E, C) 0.5 g LYSO/kg diet, D) 1 g LYSO/kg diet, E) 0.5 g LYSO + Vit. E, F) 1 g LYSO + Vit. E. The histological structure of the intestine presented the appearance of intestinal villi (red arrowhead), intestinal glands (IG), lamina muscularis mucosae (m), and muscularis externa (M), which was covered by serosa (blue arrowhead) outwardly. Stain, H&E. Bar, 100 μm. Regarding the morphological examination of the liver of broiler chickens presented in Figure 2, the control birds (Fig. 2A) showed normal hepatic architecture, characterized by hepatocytes with centrally positioned nuclei and arranged in cords, one or two cells thick, and separated by blood sinusoids surrounding the central vein. Additionally, Vit E supplementation alone (G2) enhanced the morphological appearance of hepatocytes (Fig. 2B). Broilers supplemented with 0.5 g LYSO/kg of diet (G3) displayed hepatic structures showing no differences from the control group, with further enhancement at 1 g LYSO/kg of diet (G4) (Fig. 2C-D). Co-supplementation with LYSO + Vit. E further improved hepatic architecture, particularly at the 0.5 g LYSO/kg diet (G5) (Fig. 2E-F).Figure 2Hepatic photomicrograph in broiler chickens supplemented with vitamin E and lysolecithin (LYSO). A): control, B) vitamin E, C) 0.5 g LYSO/kg diet, D) 1 g LYSO/kg diet, E) 0.5 g LYSO + Vit E, F) 1 g LYSO + Vit. E. The histological structure of the liver shows hepatocytes (blue arrowhead) and the central vein (red arrowhead). Stain, H&E. Bar, 100 μm. Hepatic photomicrograph in broiler chickens supplemented with vitamin E and lysolecithin (LYSO). A): control, B) vitamin E, C) 0.5 g LYSO/kg diet, D) 1 g LYSO/kg diet, E) 0.5 g LYSO + Vit E, F) 1 g LYSO + Vit. E. The histological structure of the liver shows hepatocytes (blue arrowhead) and the central vein (red arrowhead). Stain, H&E. Bar, 100 μm. Serum biochemical changes The serum biochemical changes in broiler chickens in response to vitamin E and/or LYSO supplementation are summarized in Table 6. No significant changes in serum protein profile (total protein, albumin, and globulin), total cholesterol, and creatinine among groups (P > 0.05). Conversely, the liver function-related enzymes responded differently to the vitamin E and/or LYSO supplementation (P < 0.05), with birds fed vitamin E (G2) and 1 g LYSO + vitamin E (G6) showing the lowest ALT activity. The AST demonstrated the same trend of reduction in birds of G2 (Vit E alone), G5 (0.5 g LYSO + Vit. E), and G6 (1 g LYSO + Vit E). On the other hand, serum lipid profile parameters, including triglycerides and LDL, were significantly reduced in response to dietary supplements, with the lowest concentrations in those fed 1 g LYSO + Vit E (G6) and 0.5 g LYSO + Vit E (G5) supplemented diets, respectively (P < 0.05), relative to the control. Moreover, dietary supplements (vitamin E and/or LYSO) increased HDL concentrations, with birds in G6 having the highest levels (P < 0.05).Table 6Serum biochemical parameters of broiler chickens supplemented with vitamin E and lysolecithin (LYSO).ParameterControlVit E0.5 g LYSO1 g LYSO0.5 g LYSO + Vit E1 g LYSO + Vit EP-valueTotal Protein (g/dl)6.98±0.257.33±0.697.52±0.288.23±0.188.40±0.418.05±0.310.117Albumin (g/dl)3.58±0.454.53±0.444.00±0.384.07±0.434.85±0.424.45±0.280.323Globulin (g/dl)3.63±0.264.10±0.424.33±0.304.05±0.434.05±0.364.23±0.230.780ALT (U/L)127.77±2.21a15.08±2.02b26.53±2.38a23.65±1.63ab19.9±0.63ab16.35±2.66b0.001AST (U/L)235.28±2.4a24.75±1.93b34.83±1.92a34.05±1.25a20.33±1.23b21.75±1.85b0.0001Creatinine (mg/dl)1.08±0.110.75±0.210.60±0.130.98±0.140.55±0.150.53±0.050.05Cholesterol (mg/dl)126.02±7.36122.28±1.37117.88±3.17112.83±2.50117.55±5.47116.10±2.820.352Triglyceride (mg/dl)118.45±2.67a104.5±1.89ab114.02±4.49ab115.98±3.69ab110.6±3.38ab101.28±2.97b0.011LDL (mg/dl)348.32±2.29a34.47±1.51ab38.1±5.00ab32.63±5.28ab27.87±3.04b28.40±1.97b0.006HDL (mg/dl)432.15±3.23b41.58±2.2ab45.35±5.14ab45.40±3.46ab42.53±2.52ab48.25±2.81a0.048Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05.1Alanine aminotransferase,2aspartate aminotransferase,3low-density lipoprotein,4high-density lipoprotein. Table 6Serum biochemical parameters of broiler chickens supplemented with vitamin E and lysolecithin (LYSO).ParameterControlVit E0.5 g LYSO1 g LYSO0.5 g LYSO + Vit E1 g LYSO + Vit EP-valueTotal Protein (g/dl)6.98±0.257.33±0.697.52±0.288.23±0.188.40±0.418.05±0.310.117Albumin (g/dl)3.58±0.454.53±0.444.00±0.384.07±0.434.85±0.424.45±0.280.323Globulin (g/dl)3.63±0.264.10±0.424.33±0.304.05±0.434.05±0.364.23±0.230.780ALT (U/L)127.77±2.21a15.08±2.02b26.53±2.38a23.65±1.63ab19.9±0.63ab16.35±2.66b0.001AST (U/L)235.28±2.4a24.75±1.93b34.83±1.92a34.05±1.25a20.33±1.23b21.75±1.85b0.0001Creatinine (mg/dl)1.08±0.110.75±0.210.60±0.130.98±0.140.55±0.150.53±0.050.05Cholesterol (mg/dl)126.02±7.36122.28±1.37117.88±3.17112.83±2.50117.55±5.47116.10±2.820.352Triglyceride (mg/dl)118.45±2.67a104.5±1.89ab114.02±4.49ab115.98±3.69ab110.6±3.38ab101.28±2.97b0.011LDL (mg/dl)348.32±2.29a34.47±1.51ab38.1±5.00ab32.63±5.28ab27.87±3.04b28.40±1.97b0.006HDL (mg/dl)432.15±3.23b41.58±2.2ab45.35±5.14ab45.40±3.46ab42.53±2.52ab48.25±2.81a0.048Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05.1Alanine aminotransferase,2aspartate aminotransferase,3low-density lipoprotein,4high-density lipoprotein. Serum biochemical parameters of broiler chickens supplemented with vitamin E and lysolecithin (LYSO). Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05. Alanine aminotransferase, aspartate aminotransferase, low-density lipoprotein, high-density lipoprotein. Phagocytosis and antioxidant enzyme response As illustrated in Figure 3, higher phagocytic activity was observed in the supplemented birds, with the highest activity in birds supplemented with 1 g LYSO + Vit. E (G6) compared to the control birds (P < 0.05). On the other hand, the phagocytic index showed numerically higher values in birds fed the combination of the two supplements (G5 and G6) (P > 0.05).Figure 3Phagocytic activity (A) and phagocytic index (B) in broiler chickens supplemented with vitamin E and lysolecithin (LYSO). Values are mean ± SE; statistical significance at P < 0.05. Phagocytic activity (A) and phagocytic index (B) in broiler chickens supplemented with vitamin E and lysolecithin (LYSO). Values are mean ± SE; statistical significance at P < 0.05. According to Table 7, antioxidant enzymes and MDA concentrations responded significantly to Vit. E and/or LYSO supplementation (P < 0.05). Broiler chickens that received the combined mixture of both supplements demonstrated significant increases in TAC, GPx, CAT, and SOD levels, along with lower MDA concentrations in liver tissue (P < 0.05) compared to the control group.Table 7Antioxidants and malondialdehyde (MDA) concentrations in broiler chickens supplemented with vitamin E and lysolecithin (LYSO).Antioxidative traitsControlVit E0.5 g LYSO1 g LYSO0.5 g LYSO+ Vit E1 g LYSO+ Vit EP-valueTAC (mmole/ g tissue)11.52±0.19b2.08±0.28ab1.63±0.19b1.54±0.31b2.07±0.27ab2.85±0.17a0.008MDA (mmole/ g tissue)235.11±5.22a23.12±3.19ab31.40±1.58a25.91±1.67ab21.28±2.29ab16.75±3.41b0.007GPX (U/g tissue)33.54±0.16c5.53±0.79abc4.75±0.62bc3.62±0.15c7.12±0.78ab8.04±0.50a0.0001CAT (U/g tissue)410.68±0.66b14.07±3.4ab18.30±4.11ab16.96±2.28ab22.33±1.09a25.07±2.22a0.011SOD (U/g tissue)512.63±1.99b17.31±3.59ab18.16±2.51ab23.09±4.76ab23.84±2.23ab30.93±2.27a0.011Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05.1total antioxidant capacity;2Malondialdehyde;3glutathione peroxidase;4catalase;5superoxide dismutase. Table 7Antioxidants and malondialdehyde (MDA) concentrations in broiler chickens supplemented with vitamin E and lysolecithin (LYSO).Antioxidative traitsControlVit E0.5 g LYSO1 g LYSO0.5 g LYSO+ Vit E1 g LYSO+ Vit EP-valueTAC (mmole/ g tissue)11.52±0.19b2.08±0.28ab1.63±0.19b1.54±0.31b2.07±0.27ab2.85±0.17a0.008MDA (mmole/ g tissue)235.11±5.22a23.12±3.19ab31.40±1.58a25.91±1.67ab21.28±2.29ab16.75±3.41b0.007GPX (U/g tissue)33.54±0.16c5.53±0.79abc4.75±0.62bc3.62±0.15c7.12±0.78ab8.04±0.50a0.0001CAT (U/g tissue)410.68±0.66b14.07±3.4ab18.30±4.11ab16.96±2.28ab22.33±1.09a25.07±2.22a0.011SOD (U/g tissue)512.63±1.99b17.31±3.59ab18.16±2.51ab23.09±4.76ab23.84±2.23ab30.93±2.27a0.011Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05.1total antioxidant capacity;2Malondialdehyde;3glutathione peroxidase;4catalase;5superoxide dismutase. Antioxidants and malondialdehyde (MDA) concentrations in broiler chickens supplemented with vitamin E and lysolecithin (LYSO). Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05. total antioxidant capacity; Malondialdehyde; glutathione peroxidase; catalase; superoxide dismutase. Gene expression analysis As shown in Figure 4, GHR and IGF-1 genes were significantly upregulated (P < 0.05) in the supplemented groups relative to the control birds, with the highest expression recorded in G6 (1 g LYSO + Vit E) (P < 0.05). Dietary supplements didn’t alter the expression of fatty acid synthetase (FAS) (P > 0.05), while they modified ACC expression (P < 0.05) (Figure 5). ACC expression was significantly downregulated in birds fed 1 g LYSO/kg (G4), 0.5 g LYSO + Vit E (G5), and 1 g LYSO + Vit E (G6) compared to the other groups, including the control. Moreover, broiler chickens supplemented with LYSO and vitamin E upregulated the antioxidant genes (SOD, GPx, and CAT) and immune response-related genes (IL-10 and IL-1β), as illustrated in Figure 6, Figure 7, respectively.Figure 4Growth-related gene expression in broiler chickens supplemented with vitamin E and lysolecithin (LYSO). Growth hormone receptor (GHR) (A) and insulin-like growth factor (IGF-1) (B). Values are mean ± SE; statistical significance at P < 0.05.Figure 5Fat metabolism-related gene expression in broiler chickens supplemented with vitamin E and lysolecithin (LYSO). Fatty acid synthetase (FAS) (A) and acetyl-CoA carboxylase (ACC) (B). Values are mean ± SE; statistical significance at P < 0.05.Figure 6Antioxidant-related gene expression in broiler chickens supplemented with vitamin E and lysolecithin (LYSO). Superoxide dismutase (SOD) (A), glutathione peroxidase (GPX) (B), and Catalase (CAT) (C). Values are mean ± SE; statistical significance at P < 0.05.Figure 7Immune response-related gene expression in broiler chickens supplemented with vitamin E and lysolecithin (LYSO). Interleukin10 (IL10) (A), and interleukin1β (IL1β) (B). Values are mean ± SE. Statistical significance at P < 0.05. Growth-related gene expression in broiler chickens supplemented with vitamin E and lysolecithin (LYSO). Growth hormone receptor (GHR) (A) and insulin-like growth factor (IGF-1) (B). Values are mean ± SE; statistical significance at P < 0.05. Fat metabolism-related gene expression in broiler chickens supplemented with vitamin E and lysolecithin (LYSO). Fatty acid synthetase (FAS) (A) and acetyl-CoA carboxylase (ACC) (B). Values are mean ± SE; statistical significance at P < 0.05. Antioxidant-related gene expression in broiler chickens supplemented with vitamin E and lysolecithin (LYSO). Superoxide dismutase (SOD) (A), glutathione peroxidase (GPX) (B), and Catalase (CAT) (C). Values are mean ± SE; statistical significance at P < 0.05. Immune response-related gene expression in broiler chickens supplemented with vitamin E and lysolecithin (LYSO). Interleukin10 (IL10) (A), and interleukin1β (IL1β) (B). Values are mean ± SE. Statistical significance at P < 0.05. Breast meat quality As shown in Table 8, dietary supplementation of vitamin E and/or LYSO significantly affected the meat-water holding capacity, tenderness, and color (P < 0.05), with no effect on meat pH among groups (P > 0.05) compared to the control. Birds raised on a 1 g LYSO/kg diet + Vit E-enriched diet (G6) exhibited the highest values of these parameters, followed by birds receiving the Vit E-supplemented diet (G2) (P < 0.05).Table 8Breast meat quality of broiler chickens supplemented with vitamin E and lysolecithin (LYSO).ParameterControlVit E0.5 g LYSO1 g LYSO0.5 g LYSO + Vit E1 g LYSO+ Vit EP-ValueWater holding capacity6.77±0.15c8.70±0.38ab8.17±0.13ab7.83±0.16b8.77±0.20ab8.93±0.17a0.0001Tenderness4.60±0.07 d5.82±0.18ab4.85±0.21cd4.93±0.10 cd5.33±0.09bc6.43±0.17a0.0001PH6.27±0.156.43±0.166.20±0.046.25±0.036.50±0.076.43±0.110.331Color0.34±0.10bc0.47±0.13b0.36±0.03bc0.25±0.09c0.45±0.12bc0.71±0.04a0.0001Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05. Table 8Breast meat quality of broiler chickens supplemented with vitamin E and lysolecithin (LYSO).ParameterControlVit E0.5 g LYSO1 g LYSO0.5 g LYSO + Vit E1 g LYSO+ Vit EP-ValueWater holding capacity6.77±0.15c8.70±0.38ab8.17±0.13ab7.83±0.16b8.77±0.20ab8.93±0.17a0.0001Tenderness4.60±0.07 d5.82±0.18ab4.85±0.21cd4.93±0.10 cd5.33±0.09bc6.43±0.17a0.0001PH6.27±0.156.43±0.166.20±0.046.25±0.036.50±0.076.43±0.110.331Color0.34±0.10bc0.47±0.13b0.36±0.03bc0.25±0.09c0.45±0.12bc0.71±0.04a0.0001Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05. Breast meat quality of broiler chickens supplemented with vitamin E and lysolecithin (LYSO). Data are presented as mean ± standard error, and means within the same row bearing different superscripts differ significantly at P < 0.05. Discussion According to the current knowledge, this study is the first to report the combined effects of LYSO and vitamin E on broiler growth, physiological functions, and meat quality. The present study demonstrated significant improvements in birds' weight gain and FCR, particularly in those receiving 1 g LYSO + Vit E, which achieved the highest productive performance among groups. The enhanced bird performance observed in the current study was achieved without affecting feed intake, suggesting improved feed utilization rather than increased FI. These results agree with findings obtained by Ahmad et al. (2023); Boontiam et al. (2017); Movagharnejad et al. (2020); Zhang et al. (2025), who documented beneficial effects of LYSO supplementation on broiler growth performance. Regarding vitamin E, its effect on broiler growth is inconsistent across the literature. Some studies reported enhanced performance, particularly under stress conditions such as heat stress (Calik et al., 2022), when combined with other nutrients such as Se, vitamin C, and zinc (Beura et al., 2012; Hossain et al., 2025), or no effect on performance (Kim et al., 2010; Habibian et al., 2016; Sadiq et al., 2023). In the current study, vitamin E supplementation alone showed moderate improvements, but when added to the LYSO, birds achieved higher performance compared to the individual treatments. This result suggests a synergistic effect of the two supplements when combined. The observed improvements in growth were positively correlated with enhanced intestinal morphology and upregulated gene expression of the growth-related genes assessed in the present investigation. We hypothesized that the growth-stimulating effect observed may be attributed to the emulsifying action of LYSO, which could improve fat digestion, alongside oxidative stability via the vitamin E antioxidant effect; together, these would enhance nutrient utilization and increase energy availability for growth. In the same regard, lysolecithin stimulated higher expression of genes involved in amino acid transport and lipid metabolism, such as FABP1 and CD36, enhancing nutrient absorption and growth (Zhang et al., 2022; Van Hoeck et al., 2025). In support, LYSO supplementation was associated with enhanced intestinal structure and nutrient utilization, resulting in better feed efficiency and overall growth (Wealleans et al., 2020; Haetinger et al., 2021; Eid et al., 2025). Addressing the digestibility of different nutrients and digestive enzyme levels in response to this experimental design is recommended in further studies to confirm the positive effects of both supplements combined. In the present study, LYSO dietary addition (0.5-1 g/kg of diet), particularly when combined with vitamin E, modulated carcass traits, demonstrated by increased breast muscle yield and lower abdominal fat content. These improvements associated with additive supplementation would be linked to enhanced nutrient utilization, which was redirected toward lean tissue deposition instead of being utilized for fat deposition and consequently improved carcass traits. This interpretation requires future digestibility trials and carcass composition analysis. Earlier studies documented similar responses with LYSO supplementation (Movagharnejad et al., 2020; Eid et al., 2025; Fayed et al., 2026). These benefits would be associated with the emulsifying action of LYSO, enhancing nutrient digestion and absorption, including fat and protein, as well as improved intestinal morphology (Boontiam et al., 2017; Fayed et al., 2026), as confirmed in the current study, which facilitates better nutrient absorption, including fat-soluble vitamins, and contributes to improved carcass traits. In previous studies, vitamin E supplementation had insignificant effects on carcass yield or weight of different body cuts (Rayani and Mutia, 2017; Pečjak et al., 2022), whereas other reports showed improvements when combined with other nutrients such as Se under heat stress (Bora et al., 2024). Similarly, Li et al. (2009) and Zhang et al. (2021) reported that dietary addition of vitamin E lowered abdominal fat content in broiler chickens. The lower fat deposition in the current study could also be linked to the down-regulation of ACC gene expression obtained in birds fed 1 g LYSO or those that received the combined mixture of LYSO + vitamin E. The lower abdominal fat in the supplemented groups was reflected in enhanced carcass characteristics, which is advantageous where leaner carcasses are highly desirable in commercial poultry production. The synergistic effects of LYSO and vitamin E on breast muscle yield need further investigation of other pathways regulating protein synthesis. To understand the mechanism behind the improvements in growth response and lower abdominal fat content, we assessed the effects of our experimental design on genes regulating growth and lipid metabolism. In the current study, dietary supplements, vitamin E and/or LYSO, were associated with higher expression of the growth-regulating genes GHR and IGF-1, with the highest expression found in birds receiving both supplements combined. In support, Zhang et al. (2022) reported that lysolecithin supplementation in broilers upregulated the expression of genes involved in fatty acid transport (CD36, and FABP1), amino acid transport (CAT1, y+, LAT1), and growth regulation (IGF1, GH, MYOD1, and MYOG), indicating a growth-promoting effect of LYSO. Also, Khalifa et al. (2021) documented upregulation of these genes with vitamin E and Se supplementation in broilers, attributing this response to their antioxidant effects, which was confirmed in several studies (Kumbhar et al., 2018; Niu et al., 2018). The obtained result would partially explain the enhanced growth in these groups through the combined effect of both supplements, which stimulated higher expression of GHR and IGF. Regarding the fat metabolism-regulating genes, vitamin E and/or LYSO supplementation were associated with reduced expression of ACC, which is the key regulatory enzyme controlling fatty acid synthesis. This result suggested that these supplements modulate fat deposition inside the body through altering the transcriptional regulation of lipogenic genes, particularly ACC, which was more sensitive to our experimental design than FAS. Aligning with the obtained result, Wang et al. (2024) found that emulsifier (lecithin and lysolecithin mixture) addition resulted in lower mRNA expression levels of FAS and ACC in broiler liver. Supporting the obtained results, Zhang et al. (2021) found that the addition of vitamin E to the broiler diet was associated with suppression of lipid synthesis regulators, including FAS, acetyl-CoA carboxylase alpha, and acyl-CoA synthetase long-chain family member 1. The present study assessed only two lipogenesis-related genes, ACC and FAS; thus, future research should expand the molecular analysis to include genes regulating fatty acid oxidation and lipid transport to better understand the mechanism by which LYSO+ vitamin E co-supplementation influences abdominal fat deposition. Intestinal morphology serves as an important indicator of gut health in broilers. The effect of vitamin E and/or LYSO supplementation extended to intestinal morphology, which demonstrated significant improvements in all assessed morphological parameters, including villus height and width, crypt depth, and muscularis thickness. These results were clear in birds that received both supplements in combination, which were correlated with enhanced overall growth performance. The beneficial effects observed in response to LYSO dietary addition could be associated with its stimulatory effect on jejunal epithelium genes, particularly those related to collagen, extracellular matrix, and integrins, leading to enhanced collagen deposition and villus length (Brautigan et al., 2017), upregulated genes like claudin-3, which is associated with intestinal health (Chen et al., 2019), genes related to intestinal health and development in broilers (Li et al., 2022). Also, it could be linked to the antibacterial effect of LYSO, positively affecting the gut microbiota, favoring beneficial ones, supporting intestinal morphology, and enhancing gut function. In the same regard, Salari et al. (2024) found that LYSO supplementation was accompanied by a higher Lactobacillus population in the caeca. As shown, vitamin E supplementation was also associated with enhanced intestinal morphology, particularly when combined with LYSO, suggesting that it improves the beneficial effect of LYSO or acts as a complementary compound through its antioxidant effect, reducing oxidative stress on intestinal epithelium. Vitamin E contributes significantly to maintaining the integrity and function of intestinal epithelial cells by enhancing intestinal barrier integrity, alleviating oxidative stress, and modulating inflammatory responses (Pitargue et al., 2019; Korkmaz, 2023). Measurement of tight junction proteins in the intestine and nutrient transporters such as GLUT2, PEPT1, SGLT1, and amino acid transporters would help in understanding the observed morphological improvements in response to our experimental design. Considering the biochemical parameters, vitamin E and/or LYSO addition was associated with enhanced liver function (lower levels of liver function-related enzymes) and lipid profile demonstrated by lower serum triglycerides and LDL, along with higher HDL levels and enhanced antioxidant status. The lack of changes in serum concentrations of total protein, albumin, globulin, and creatinine suggested that dietary treatments don’t compromise protein synthesis or kidney function. As intracellular enzymes, AST and ALT are liberated into the bloodstream when hepatocytes are damaged or cellular membrane permeability is altered; therefore, their elevated serum activities are widely considered indicators of liver injury (Elkhaiat et al., 2025). The observed decline in AST and ALT activities, particularly in birds raised on both supplements, may reflect potential hepatoprotective effects of the co-supplements, which contributed to maintaining hepatocellular membrane integrity by lowering oxidative stress. Supporting this finding was the absence of histopathological alterations in the liver tissue of birds fed the combined mixture, together with the enhanced antioxidant status assessed in the current study. As observed, vitamin E addition to the LYSO-containing diet lowered enzyme activity compared to single LYSO supplementation. We hypothesized that LYSO, with its emulsifying properties, enhances lipid digestion and absorption and, in turn, improves the bioavailability of dietary vitamin E (a fat-soluble vitamin), thereby potentiating its antioxidant and membrane-stabilizing effects in the liver, improving overall health. This result is consistent with Cai et al. (2024); Eid et al. (2025) with lysolecithin or lysophospholipid supplementation, and Khalifa et al. (2021) when vitamin E was added to the broiler diet. In the current study, liver tissue was evaluated only descriptively. The absence of quantitative hepatocyte morphometry and sinusoidal area measurements limits definitive conclusions regarding hepatic structural integrity. Therefore, these findings should be confirmed in future studies using appropriate morphometric analyses. Regarding the serum lipid profile, lower triglyceride and LDL levels in all supplemented groups, along with higher HDL levels, reflect the role of these supplements in regulating lipid metabolism and transport inside the body. Superior improvements in the lipid profile were obtained in birds fed the combined mixture of LYSO with vitamin E compared to the addition of each supplement alone. The enhanced response with lysolecithin could be associated with enhanced lipid digestion, absorption, and metabolism, resulting in favorable changes in the lipid profile (Zhang et al., 2025). Also, it could be linked to its effect on lipid metabolism-regulating genes, as reported by the upregulation of genes associated with intestinal fatty acid transport (Cd36, Fatp4, Dgat2, Apob, and Mttp), downregulation of hepatic lipogenic genes (FAS and ACC), and increasing expression of genes involved in hepatic triglyceride synthesis, transport, and breakdown in broilers (Wang et al., 2024). The present results are consistent with those of Mohiti-Asli et al. (2025) and Zhang et al. (2025). The mechanism by which vitamin E influences lipid metabolism could be related to its antioxidant function, which protects cell membranes from oxidative damage and maintains lipid stability (Pompeu et al., 2018). The observed improvements in the serum lipid profile are consistent with the previously mentioned reduction in abdominal fat percentage and the downregulation of ACC gene expression recorded in the current study. These results suggest that both supplements, particularly when combined, affect lipid metabolism by suppressing de novo lipogenesis through downregulation of ACC expression, while promoting the utilization or clearance of circulating triglycerides, which results in lower lipid accumulation, particularly abdominal fat. Overall, the hepatoprotective effects, as indicated by lower ALT and AST activities and an improved lipid profile, suggest that LYSO and vitamin E supplementation may reduce the risk of metabolic disorders, support liver function, and improve the overall health of broilers. In addition, LYSO and/or vitamin E supplementation were associated with significantly improved innate immune response. This finding was confirmed by higher phagocytic activity across the supplemented groups, with the highest activity observed in birds that received 1 g/kg LYSO + vitamin E, along with upregulation of genes linked to immune response (IL-10 and IL-1β), suggesting an immunostimulatory effect. According to Konjufca et al. (2004), supplemental vitamin E enhances Fc-receptor-mediated phagocytic activity of macrophages in young broilers and modulates both humoral and cellular immune responses. Also, Lee et al. (2020) reported that lysophosphatidylcholine improves bactericidal activity by stimulating phagosome maturation through activation of the NF-κB signaling pathway in Salmonella-infected mouse macrophages. In the same context, vitamin E exerts immunomodulatory effects by regulating cyclooxygenase and lipoxygenase pathways and influencing the production of immune mediators, including prostaglandins and leukotrienes (Leshchinsky and Klasing, 2003), enhancing both innate and cellular immune functions in poultry (Perez-Carbajal et al., 2010). On the other hand, lysolecithin positively affects the immune response in poultry by reducing key inflammatory markers (interleukin-6 and endotoxin levels) (Cai et al., 2024), enhancing antioxidant capacities (Eid et al., 2025), and reducing proinflammatory cytokines such as IL-1 (Boontiam et al., 2017). Also, promoting beneficial morphological changes that enhance gut structure and the physical barriers against pathogens; supporting nutrient absorption (Brautigan et al., 2017; Li et al., 2022); and upregulating immune-related genes such as IL8-like 2 (Cloft et al., 2021). Overall, the beneficial effects of both supplements, especially when combined, could partially explain their role in enhancing birds' innate immune response. Antioxidant enzymes, including SOD, catalase, and GPx, represent the primary enzymatic defense against ROS, while MDA is a well-recognized biomarker of lipid peroxidation (Surai et al., 2019). The hepatic antioxidants assessed in the current study were improved, as shown by higher levels of the antioxidants (TAC, GPx, CAT, and SOD) and higher expression of antioxidant-related genes (SOD, catalase, and GPx). These changes were accompanied by lower MDA levels, indicating enhanced antioxidant status, with the strongest effects observed when both supplements were provided together. Similarly, Eid et al. (2025) documented that the incorporation of 0.5 or 1 g LPL/ kg diet stimulated higher phagocytic activity and index and improved antioxidant enzymes as well as mitigated the immunosuppressive effects of dexamethasone-induced oxidative stress in broiler chickens. Similar improvements in the antioxidant status with lysolecithin or lysophospholipid supplementation were also reported (Ani et al., 2024; Fayed et al., 2026). This could be linked to the emulsifying effect of LYSO, helping to improve fat utilization, leading to more efficient energy metabolism and reduction of oxidizable lipid accumulation within tissues, thereby lowering oxidative burden and lipid peroxidation. Also, it may be related to the powerful antioxidant effect of vitamin E, and its ability to scavenge free radicals and attenuate lipid peroxidation (Pompeu et al., 2018). Supporting these findings, Niu et al. (2018); Elgendey et al. (2022); Oni et al. (2024) reported that vitamin E, alone or combined with selenium, has been shown to enhance antioxidant defenses in broilers by increasing antioxidant enzyme activities, reducing lipid peroxidation, and upregulating antioxidant-related gene expression, thereby improving oxidative status and meat quality. Nuclear Factor Erythroid 2-Related Factor 2 (Nrf2) plays a central role in regulating the antioxidant defense system, acting at sites of free radical generation and promoting the expression of primary antioxidant enzymes, including SOD, GPx, and catalase (Surai et al., 2019). The obtained result suggested that the combination of both supplements may activate Nrf2, which consequently resulted in transcriptional upregulation of antioxidants. The current study did not examine Nrf2 expression, which would have provided direct evidence for the contribution of this pathway. Additionally, the current study demonstrated improvements in breast meat quality (WHC, tenderness, and color intensity), with the most pronounced effects observed in birds receiving both supplements combined, particularly at 1 g/kg LYSO + vitamin E and the vitamin E-supplemented group. These changes could be linked to the positive effects of both supplements on lipid metabolism and antioxidant status demonstrated by increased activities of SOD, GPx, and CAT and their expression levels and lowered lipid peroxidation mentioned earlier. We hypothesized that this enhanced antioxidant status improves cellular integrity, reduces lipid oxidation, and decreases pigment oxidation, thus protecting both lipid and protein components of the muscle cell from oxidative changes, so maintaining the physical structure and enhancing the muscle’s ability to retain water, tenderness, and color. Supporting this, Niu et al. (2018) stated that vitamin E enhanced meat quality in broilers by upregulating genes involved in antioxidant enzymes. Consistent with these findings, previous reports found that Se and vitamin E supplementation significantly improved WHC of breast meat through their antioxidant protection (Albergamo et al., 2022), was effective in preventing the deterioration of meat quality in broilers subjected to chronic heat stress when supplemented alone (200 mg/kg) (Hashizawa et al., 2013), and improved lipid oxidative stability via increasing VE retention in broiler muscles (Xu et al., 2021). In the same regard, Khatun et al. (2020) reported improvements in meat redness with vitamin E supplementation attributed to its ability to reduce lipid oxidation, which indirectly retards myoglobin oxidation and protects muscle tissues from oxidative damage. Similar improvements in meat quality were also reported by Shen et al. (2021) and Eid et al. (2025) when lysophospholipids and lecithin were added to the broiler diet, which could be linked to enhanced lipid metabolism. In addition, the lack of treatment effects on muscle pH suggested that these additives didn’t significantly affect the glycolytic metabolism of muscle postmortem, which is consistent with (Niu et al., 2018; Vieira et al., 2021). The current experiment was limited in some points regarding the meat quality evaluation. We didn’t measure the internationally accepted color parameters L* (lightness), a* (redness), and b* (yellowness), which would give more detailed information on the effects of the dietary treatments on meat color characteristics. Also, the meat quality parameters were assessed at only one postmortem time point, which limited the ability to identify the whole postmortem muscle changes, so evaluating these parameters at different intervals post-slaughter should be considered in further studies. Although we found improvements in WHC, tenderness and color, we didn’t measure the oxidative stability markers such as TBARS (for lipid oxidation) and carbonyl content (for protein oxidation) or the vitamin E concentration in the muscle tissue. These measurements would have been significant in supporting the proposed antioxidant mechanism and linking dietary vitamin E supplementation, its accumulation, and enhanced oxidative stability in meat. Conclusion Based on the previously mentioned results, dietary vitamin E and lysolecithin supplementation represent a valuable nutritional approach for enhancing broiler growth, health status, and meat quality. The combination of 1 g/kg LPL and vitamin E achieved the most pronounced effects, demonstrating combined benefits that exceeded their individual supplementation. This combination enhanced growth and carcass traits, intestinal and hepatic morphology, improved lipid profile, boosted phagocytic activity and hepatic antioxidant enzymes (SOD, GPx, and CAT), upregulated antioxidant and immune gene expression (IL-10, IL-1β), and meat quality parameters without affecting meat pH or serum protein and renal markers. Future studies should assess the efficacy of this combination against environmental stressors, such as heat stress. Author contributions Abeer A. Kirrella: contributed to the conception and development of the study, the experimental design and implementation of the dietary supplementation trial, the evaluation of growth parameters and serum biochemical parameters, and participated in the interpretation of the findings. Karima El-Naggar: contributed to the development of the experimental design and implementation of the vitamin E and lysolecithin supplementation treatments, participated in scientific interpretation of the results and critical revision of the manuscript as well as preparation the revised manuscript. Abeer G. Zaki: contributed substantially to the molecular aspects of the study, including the evaluation and interpretation of gene-expression responses associated with vitamin E and lysolecithin supplementation, and contributed to the scientific discussion and critical revision of the manuscript. Safaa E. Abdo: contributed substantially to the experimental work, participated in the analysis and interpretation of gene-expression and physiological findings, scientific evaluation and interpretation of the results, discussion of the findings, and critical revision of the manuscript. Eman A. Manaa: contributed to the molecular aspects of the trail, including the evaluation and interpretation of gene-expression responses associated with vitamin E and lysolecithin supplementation, scientific discussion, and critical revision of the manuscript. Asmaa F. Khafaga: contributed substantially to the pathological aspects of the study, scientific development of the study, funding acquisition, participated in the interpretation of oxidative stress-related findings, participated in the improvement of the manuscript. Ayham Abdulkader: participated in the interpretation and integration of the growth-markers, biochemical, and antioxidant, development of the scientific discussion, editing the manuscript and participated in the improvement of the manuscript. Mahmoud Alagawany: contributed substantially to the conception and scientific development of the study, participated in nutritional analysis and interpretation of nutrition-related findings, and scientific discussion, as well as preparation and critical revision of the manuscript. Yahya Eid: contributed to the experimental planning and supervision, evaluation and interpretation of the experimental findings related to physiology, scientific discussion, and critical revision of the manuscript. Ibrahim A. Elkhaiat: contributed substantially to the experimental implementation, scientific discussion of the breeding findings, participated in the analysis and interpretation of gene-expression data and critical revision. All authors participated actively in the scientific development and completion of the work, critically reviewed the manuscript, approved the final version, and agreed to be accountable for the integrity and accuracy of the work. Funding information This work was supported by the Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia [Grant No. KFU261737]. Disclosures The authors confirm that they have no conflict of interest.